ORIC
Oric Pharmaceuticals Inc
NASDAQ: ORIC · HEALTHCARE · BIOTECHNOLOGY
$9.44
-2.18% today
Updated 2026-04-29
Market cap
$977.21M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.47
Dividend yield
—
52W range
$5 – $15
Volume
2.1M
Oric Pharmaceuticals Inc (ORIC) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — | — | — | — | — | — |
| Cost of revenue | $900000.00 | $900000.00 | $1.00M | $970000.00 | $897000.00 | $966000.00 | $1.03M | $1.11M | $1.22M |
| Gross profit | $-900000.00 | $-900000.00 | $-1.00M | $-970000.00 | $-897000.00 | $-966000.00 | $-1.03M | $-1.11M | $-1.22M |
| Gross margin | — | — | — | — | — | — | — | — | — |
| R&D | $19.13M | $19.03M | $22.84M | $60.76M | $56.86M | $61.68M | $85.17M | $114.07M | $109.82M |
| SG&A | $3.42M | $3.35M | $5.72M | $13.42M | $22.01M | $25.09M | $25.61M | $28.82M | $33.19M |
| Operating income | $-22.54M | $-22.37M | $-28.57M | $-74.19M | $-78.87M | $-91.77M | $-110.78M | $-142.90M | $-143.00M |
| Operating margin | — | — | — | — | — | — | — | — | — |
| EBITDA | $-21.13M | $-20.46M | $-25.88M | $-48.37M | $-77.97M | $-85.80M | $-109.75M | $-126.74M | $-128.25M |
| EBITDA margin | — | — | — | — | — | — | — | — | — |
| EBIT | $-22.03M | $-21.36M | $-26.88M | $-49.34M | $-78.87M | $-86.77M | $-110.78M | $-127.85M | $-129.47M |
| Interest expense | $0.00 | $1.01M | $1.69M | $306000.00 | $141000.00 | $2.65M | — | — | — |
| Income tax | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-22.03M | $-21.36M | $-26.88M | $-73.70M | $-77.68M | $-89.12M | $-100.70M | $-127.85M | $-129.47M |
| Net income growth (YoY) | — | +3.0% | -25.8% | -174.2% | -5.4% | -14.7% | -13.0% | -27.0% | -1.3% |
| Profit margin | — | — | — | — | — | — | — | — | — |